Work

A Phase 2 Study to Evaluate the Efficacy and Safety of Simtuzumab in Adult Subjects with Primary, Post Polycythemia Vera (PV) or Post Essential Thrombocythemia (ET) Myelofibrosis

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.2810.2810

Authors: Srdan Verstovsek, Michael R. Savona, Ruben A. Mesa, Stephen Oh, Hua Dong, Dung Thai, Jason Gotlib

Institutions: The University of Texas MD Anderson Cancer Center, Vanderbilt University, Mayo Clinic in Arizona, Washington University in St. Louis, Gilead Sciences (United States), Stanford Medicine, Stanford Cancer Institute, Stanford University

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2593847736

FWCI: 0.559

Cites:

Cited by: 4

Related to: 10